Beijing Strong Biotechnologies,Inc.’s Net Profit Dropped 16% in 2022

Beijing Strong Biotechnologies,Inc. (北京九强生物技术股份有限公司) (300406.SZ) reported a net profit of 394.5 million yuan in 2022, down 16% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, down 5.5% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 29.1%.